Stryker Co. (NYSE:SYK) Shares Purchased by Horizon Wealth Management LLC

Horizon Wealth Management LLC lifted its holdings in Stryker Co. (NYSE:SYK) by 5.9% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,139 shares of the medical technology company’s stock after purchasing an additional 63 shares during the period. Horizon Wealth Management LLC’s holdings in Stryker were worth $424,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors also recently bought and sold shares of the company. Kohmann Bosshard Financial Services LLC acquired a new position in shares of Stryker during the 4th quarter worth about $25,000. Capital A Wealth Management LLC purchased a new position in Stryker during the fourth quarter worth about $26,000. Rakuten Securities Inc. increased its holdings in Stryker by 618.2% in the 4th quarter. Rakuten Securities Inc. now owns 79 shares of the medical technology company’s stock valued at $28,000 after purchasing an additional 68 shares during the last quarter. Centricity Wealth Management LLC purchased a new stake in Stryker during the fourth quarter worth about $30,000. Finally, BankPlus Trust Department purchased a new stake in shares of Stryker during the fourth quarter worth $33,000. Institutional investors and hedge funds own 77.09% of the company’s stock.

Insider Buying and Selling at Stryker

In related news, Director Ronda E. Stryker sold 200,000 shares of the firm’s stock in a transaction that occurred on Tuesday, May 6th. The shares were sold at an average price of $376.96, for a total transaction of $75,392,000.00. Following the completion of the sale, the director now owns 3,417,326 shares of the company’s stock, valued at $1,288,195,208.96. This trade represents a 5.53% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 5.90% of the company’s stock.

Stryker Stock Performance

Shares of SYK opened at $384.15 on Friday. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.95 and a quick ratio of 1.32. The stock has a 50-day moving average of $370.10 and a 200-day moving average of $376.03. The company has a market cap of $146.63 billion, a PE ratio of 49.50, a P/E/G ratio of 2.93 and a beta of 0.91. Stryker Co. has a one year low of $314.93 and a one year high of $406.19.

Stryker (NYSE:SYK) last posted its earnings results on Thursday, May 1st. The medical technology company reported $2.84 EPS for the quarter, topping the consensus estimate of $2.73 by $0.11. Stryker had a net margin of 13.25% and a return on equity of 23.58%. The firm had revenue of $5.87 billion for the quarter, compared to analysts’ expectations of $5.68 billion. During the same quarter last year, the firm earned $2.50 EPS. The company’s quarterly revenue was up 11.9% compared to the same quarter last year. On average, equities research analysts predict that Stryker Co. will post 13.47 EPS for the current fiscal year.

Stryker Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, July 31st. Shareholders of record on Monday, June 30th will be issued a $0.84 dividend. The ex-dividend date is Monday, June 30th. This represents a $3.36 dividend on an annualized basis and a yield of 0.87%. Stryker’s dividend payout ratio (DPR) is 45.41%.

Analysts Set New Price Targets

A number of research analysts recently commented on SYK shares. Wall Street Zen downgraded shares of Stryker from a “buy” rating to a “hold” rating in a research report on Friday. Sanford C. Bernstein set a $450.00 price target on Stryker in a research report on Monday, May 5th. Needham & Company LLC reissued a “buy” rating and issued a $442.00 target price on shares of Stryker in a research note on Friday, March 21st. JMP Securities reaffirmed a “market perform” rating on shares of Stryker in a research note on Monday, May 5th. Finally, Truist Financial upped their price objective on shares of Stryker from $390.00 to $400.00 and gave the company a “hold” rating in a research note on Monday, May 5th. Five investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. According to data from MarketBeat.com, Stryker has an average rating of “Moderate Buy” and a consensus target price of $427.30.

Stryker Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.